Cerebrovascular Diseases最新文献

{"title":"Mediterranean-DASH Intervention for Neurodegenerative Delay Diet to Improve Cognitive Function in Mild Stroke Patients: Rationale and Design of Two Replicate, Pilot Randomized Control Trials.","authors":"Qing Lin, Hui Chen, Jie Shen, Yang Tao, Lili Tang, Tao Zhang, Xiaoran Liu, Ping Zeng, Fang He, Chengjia Liu, Xin Xu, Changzheng Yuan, Lu-Sha Tong","doi":"10.1159/000547148","DOIUrl":"10.1159/000547148","url":null,"abstract":"<p><strong>Introduction: </strong>Approximately one-third of stroke survivors develop post-stroke cognitive impairment (PSCI), yet effective preventive strategies remain limited. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet was originally developed to promote cognitive health, but its effect on changes in cognitive function among mild stroke patients remains unclear. In this study, we aimed to explore the effect of MIND intervention on cognitive function among mild stroke patients. By implementing the same protocol in two independent samples, we aimed to examine whether the results are reproducible across different recruitment waves and refine protocols for future large-scale trials.</p><p><strong>Methods: </strong>The MIND Diet to Improve Cognitive Function in Mild Stroke Patients (MINDICOMS) and MINDICOMS II are two replicate, pilot, two-arm RCTs, each enrolling 60 patients aged 35-70 years with acute ischemic stroke and signs of newly onset cognitive impairment but no dementia. The participants will be randomly assigned to the MIND diet intervention group or a control group. We adapted the MIND diet for the Chinese population, recommending eleven food groups and restricting four food groups. During the 26-week intervention phase, participants in the control group will receive standard medical care along with weekly health education messages. The intervention group will receive a structured MIND diet education program, including in-hospital provision of MIND-compliant meals for 7 days, and post-discharge supplies of nuts, olive or camellia oil, whole grains, and green tea. Personalized dietary guidance and regular feedback from dietitians will be delivered via an online platform. The primary outcome measure is change in global cognitive function measured using a neuropsychological test battery at weeks 0, 13, and 26. Secondary outcomes include changes in domain-specific cognitive function, brain imaging markers, dietary behavior, the ability of daily living, mental health indicators, plasma biomarkers, and the gut microbiota composition.</p><p><strong>Conclusion: </strong>The MINDICOMS trials will generate preliminary evidence to optimize dietary strategies for cognitive improvement in stroke survivors. The comprehensive set of outcome measures will also offer a unique opportunity to explore potential biological mechanisms and generate new hypotheses for future research.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-14"},"PeriodicalIF":1.5,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144607515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Automatic Screening Risk of Stroke-Associated Pneumonia and Giving Feedback to Medical Staff Can Improve Outcomes and Save Healthcare Cost in Stroke Unit.","authors":"Shi Cheng, Junping Guo, Lin Lin, Jing Li, Wenyu Dong, Feifei Ma, Yanfang Li, Qixuan Guan, Wenrui Xing, Yanfang Liu, Runhua Zhang, Gaifen Liu, Jingjing Lu, Yi Ju, Xingquan Zhao, Yuewei Zhang, Ruijun Ji","doi":"10.1159/000547295","DOIUrl":"10.1159/000547295","url":null,"abstract":"<p><strong>Introduction: </strong>Stroke-associated pneumonia (SAP) is a major infectious complication after stroke and has adverse impact on clinical outcomes. This study investigates whether automatic screening the risk of SAP and giving feedback to medical staff would reduce the incidence of inhospital pneumonia and improve clinical outcomes in patients with acute ischemic stroke (AIS).</p><p><strong>Methods: </strong>This monocentric retrospective cohort study involved eligible inpatients in neurology department of Beijing Tiantan Hospital from June 2019 to October 2023. A quality improvement program was initiated on July 1, 2021, in which validated risk models were used to screen potential risk of SAP after stroke and feedback was automatically given to medical staff by electric medical records in real time. The primary outcome was occurrence of inhospital pneumonia after stroke. In addition, the following clinical outcomes were used including inhospital urinary tract infection, length of stay (LOS), total medical cost during hospitalization, mRS score at discharge and inhospital mortality. Multivariable logistic regression was performed to evaluate the association between the quality improvement program (after versus before) and clinical outcomes.</p><p><strong>Results: </strong>A total number of 2,010 AIS patients were included with 652 patients in pre-implementation group and 1,358 patients in post-implementation group. It was shown that the quality improvement program was significantly associated with lower incidence of inhospital pneumonia (adjusted OR 0.421, 95% CI 0.237-0.746, p = 0.003) and better functional outcome (mRS ≤2) (adjusted OR 1.332, 95% CI 1.003-1.769, p = 0.048). In addition, it was illustrated that the program was significantly associated with shorter LOS (≤7 days) (adjusted OR 3.914, 95% CI 2.865-5.347, p < 0.001) and lower total healthcare cost during hospitalization (>15,000 CNY) (adjusted OR 0.479, 95% CI 0.392-0.586, p < 0.001).</p><p><strong>Conclusion: </strong>SAP risk screening and giving feedback to medical staff is an effective way to reduce inhospital pneumonia, improve functional outcome, and save healthcare cost after stroke.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-11"},"PeriodicalIF":1.5,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144590554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Emergency MRI as the First Imaging Modality in Acute Stroke: Effect on Diagnostic Performance and Outcomes.","authors":"Zijie Wang, Yanghua Tian, Qi Li, Xueyun Liu, Yunhe Xia, Chuanqin Fang","doi":"10.1159/000547095","DOIUrl":"10.1159/000547095","url":null,"abstract":"<p><strong>Introduction: </strong>Whether shifting from computed tomography (CT) to magnetic resonance imaging (MRI) as the initial diagnostic approach in emergency assessment may offer an advantage in acute stroke care remains unclear. We sought to evaluate the impact of the MRI-first paradigm on diagnosis, workflow, and clinical outcomes in a comprehensive stroke center.</p><p><strong>Methods: </strong>In this retrospective analysis of a prospective observational cohort, consecutive patients admitted within 24 h after onset or last known well and with diagnosis of acute ischemic stroke, intracerebral hemorrhage (ICH), or transient ischemic attack (TIA) at the emergency department before (July 2022 to March 2023) and after the implementation of an MRI paradigm (April 2023 to January 2024) were included. We compared the diagnostic performance, workflow metrics, and 3-month modified Rankin Scale (mRS) between CT-first and MRI-first paradigms.</p><p><strong>Results: </strong>A total of 478 patients in the CT-first group and 488 patients in the MRI-first group with initial diagnosis of acute stroke or TIA were included. The concordance of stroke diagnosis was improved after implementation of MRI-first paradigm {95.9% (95% confidence interval [CI]: 94.1%-97.7%) vs. 91.2% (95% CI: 88.7%-93.8%), p = 0.003}. Despite a lower rate of thrombolysis and slightly prolonged door-to-needle time, fewer cases of stroke mimics were treated by thrombolysis. MRI-first paradigm was associated with favorable shift in mRS (adjusted common odds ratio [cOR] 0.65, 95% CI 0.51-0.84) at 3 months among all patients with final diagnosis of any acute stroke or TIA. MRI-first paradigm was specifically related to favorable outcome (adjusted cOR 0.61, 95% CI: 0.45-0.83) among patients with cerebral ischemia. MRI-first paradigm was not associated with functional outcomes among ICH patients.</p><p><strong>Conclusion: </strong>Implementing MRI as the first imaging modality in emergency assessment of stroke is feasible and associated with favorable clinical outcomes for cerebral ischemia.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-10"},"PeriodicalIF":1.5,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144574903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beyond Reperfusion: Adjunctive Therapies Targeting Inflammation, Edema, and Blood-Brain Barrier Dysfunction in Ischemic Stroke.","authors":"Alexander Weiss, Yuchuan Ding","doi":"10.1159/000547092","DOIUrl":"10.1159/000547092","url":null,"abstract":"<p><strong>Background: </strong>Stroke remains a leading cause of disability and death worldwide. While reperfusion therapies such as tissue plasminogen activator and mechanical thrombectomy have significantly improved stroke management, their effectiveness is limited by ischemia/reperfusion injury, which disrupts the blood-brain barrier (BBB), increases neuroinflammation, and exacerbates secondary neuronal damage. Consequently, there is an urgent need for adjunctive therapies that specifically target these secondary injury mechanisms.</p><p><strong>Summary: </strong>This review explores novel therapeutic strategies aimed at mitigating neuroinflammation, poststroke edema, and BBB permeability. Key approaches discussed include anti-inflammatory therapies targeting tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and matrix metalloproteinases (MMPs); neuromodulation by vagus nerve stimulation (VNS); and the inhibition of edema-related molecules such as sulfonylurea receptor 1 (SUR1), aquaporin-4 (AQP4), and both systemic and peripheral hypothermic cooling. While these therapies show promise in preclinical models, their clinical translation is hindered by challenges such as systemic immunosuppression, susceptibility to infection, and limited therapeutic windows. Among these therapies assessed, SUR1 inhibition and remote administration of hypothermia (RAH) are promising candidates for improving stroke outcomes.</p><p><strong>Key messages: </strong>Secondary injury from BBB disruption, inflammation, and edema remains a major barrier to optimal stroke recovery. Pharmacologic, neuromodulatory, and molecular-targeting strategies, including TNF-α, IL-6, MMP inhibition, VNS, and hypothermia, each offer distinct therapeutic mechanisms, but face critical clinical translation barriers. Among emerging therapies, RAH and SUR1 inhibition represent novel interventions that address many of the translational challenges of other therapies by addressing key mechanisms of neuroinflammation and edema with favorable safety profiles.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-10"},"PeriodicalIF":1.5,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144559310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Enlarged Translesional Pressure Gradient Drives Recruitment of Leptomeningeal Collaterals in Medically Treated Patients with Symptomatic Middle Cerebral Artery Stenosis.","authors":"Yuying Liu, Xuan Tian, Jill Abrigo, Shuang Li, Yu Liu, Linfang Lan, Haipeng Liu, Bonaventure Y M Ip, Sze Ho Ma, Karen Ma, Florence S Y Fan, Hing Lung Ip, Yannie O Y Soo, Howan Leung, Vincent C T Mok, Thomas W Leung, Xinyi Leng","doi":"10.1159/000547147","DOIUrl":"10.1159/000547147","url":null,"abstract":"<p><strong>Introduction: </strong>Evolution patterns and contributing factors of leptomeningeal collaterals (LMCs) in symptomatic intracranial atherosclerotic stenosis (sICAS) remain elusive.</p><p><strong>Methods: </strong>Patients with atherosclerotic M1 middle cerebral artery (MCA-M1) stenosis (50%-99%), who were treated medically and had CT angiography (CTA) at baseline and 1 year, were recruited. LMC status was determined by the laterality of distal vessels in anterior and posterior cerebral artery territories in baseline and 1-year CTA. Computational fluid dynamics models were constructed based on baseline and 1-year CTA, to quantify post-stenotic to pre-stenotic pressure ratio (PR) in MCA-M1 lesions. Decreased PR over 1 year indicated enlarged translesional pressure gradient.</p><p><strong>Results: </strong>Among 33 patients (median age 62 years), 18 (54.5%) and 15 (45.5%) had good and poor baseline LMCs; 11 (33.3%) and 22 (66.7%) had good and poor 1-year LMCs. Twelve (36.4%), 16 (48.5%), and 5 (15.2%) patients had worse, similar and better LMCs at 1 year versus baseline. Sixteen (48.5%) patients had decreased PR over 1 year, associated with good LMCs at 1 year (adjusted odds ratio 6.40; p = 0.038), independent of baseline LMC status.</p><p><strong>Conclusion: </strong>LMCs may evolve over time in medically treated sICAS patients, when an enlarged translesional pressure gradient may be a driving force.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-9"},"PeriodicalIF":1.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144539105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Impact of Intracranial Blood Clearance on Brain Edema as a Predictor of Delayed Cerebral Infarction following Subarachnoid Hemorrhage.","authors":"Panagiotis Fistouris, Christian Scheiwe, Juergen Grauvogel, Istvan Csok, Juergen Beck, Peter C Reinacher, Roland Roelz","doi":"10.1159/000547091","DOIUrl":"10.1159/000547091","url":null,"abstract":"<p><strong>Introduction: </strong>Brain edema is a common finding after intracranial aneurysm rupture and the severity of brain edema has been associated with the risk for delayed cerebral infarction (DCI). In this retrospective comparative study, we investigate (a) the role of brain edema for DCI development and (b) the impact of active blood clearance on the association between brain edema and DCI.</p><p><strong>Methods: </strong>This study included 799 aSAH patients treated between October 2005 and October 2019, excluding those with early mortality (<96 h). The Subarachnoid Hemorrhage Early Brain Edema Score (SEBES) was recorded in all patients. DCIs were determined by an independent rating board and neurological outcome was independently assessed by modified Rankin Scale at 6 months. Active blood clearance by cisternal lavage therapy was introduced in October 2015. Overall, 609 patients were treated before and 190 after implementation of cisternal lavage, with 61 high-risk patients (32.1%) receiving lavage. Multivariable regression models were applied to analyze the role of brain edema for DCI and a matched pairs analysis assessed the impact of cisternal lavage.</p><p><strong>Results: </strong>DCI increased the risk of poor neurological outcome (mRS 4-6) by over 10 times (OR: 10.3, 95% CI: 6.8-15.8, p < 0.001). Poor WFNS scores on admission and high blood volume in the basal cisterns and ventricles were key DCI predictors. Brain edema raised the DCI risk by 2-3 times across all SEBES grades ≥1 (OR: 1.90-2.80). Cisternal lavage was negatively associated with DCI development (OR: 0.23, 95% CI: 0.13-0.42, p < 0.001). In patients selected for cisternal lavage, there was no association between brain edema severity and DCI risk.</p><p><strong>Conclusion: </strong>Brain edema following aSAH is strongly linked to an increased risk of DCI. However, this association disappears once the underlying cause of DCI - intracranial blood - is cleared. Thus, brain edema serves as a marker of bleeding severity rather than a direct causal factor in the development of DCI.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-8"},"PeriodicalIF":1.5,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detecting Diffusion-Weighted Imaging-Negative Strokes in Rat Models of Acute Internal Carotid Artery Occlusion Using Magnetic Resonance Spectroscopy.","authors":"Haoyi Ye, Siqi Liu, Zhihua Wu, Yuping Liu, Xiaoling Li, Haili Yang, Yanyu Zhang, Rongjian Jiang, Zhengfei Yang, Zhifeng Liu","doi":"10.1159/000547134","DOIUrl":"10.1159/000547134","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to explore the potential of magnetic resonance spectroscopy (MRS) for the early diagnosis of the ischemic brain tissue with negative diffusion-weighted imaging (DWI) results in the model of acute internal carotid artery occlusion (AICAO) in rats.</p><p><strong>Methods: </strong>Fifteen rats were randomly assigned to three groups: the sham group (SHAM, n = 5), the 2-h ischemia model group (CI2H, n = 5), and the 12-h ischemia model group (CI12H, n = 5). In the experimental group, the method of AICAO was adopted to establish a right cerebral ischemia model. After the successful establishment of the model, DWI and MRS scans were first performed, and then the MRS results were recorded. Immunohistochemical analysis of zonula occludens-1 (ZO-1), neuron-specific enolase, S-100β protein, and cytochrome C (CytC) was conducted on paraffin-embedded brain sections, followed by Spearman correlation analysis between relevant parameters and these proteins.</p><p><strong>Results: </strong>Lipid (Lip) levels were lower in the SHAM group compared to the CI2H group (p < 0.05), but no significant difference was observed between the SHAM and CI12H groups. Lip was negatively correlated with ZO-1 across all groups (ρ = -0.768, p < 0.001). Lactate (Lac) levels were lower in the SHAM group than in the CI2H and CI12H groups (p < 0.05), and Lac was positively correlated with CytC across all groups (ρ = 0.801, p < 0.001). Apparent diffusion coefficient (ADC) values on the right side of the brain were lower in the CI12H group than in the SHAM group (p < 0.05), with no significant difference compared to the CI2H group. The level of N-acetyl aspartate (NAA) in the CI12H group was lower than that in the SHAM group and the CI2H group (p < 0.05), and there was no statistically significant difference in the level of NAA between the CI2H group and the SHAM group. The Choline (Cho) level in the CI12H group exhibited a statistically significant increase compared to both the SHAM and CI2H groups (p < 0.05), and there was no statistically significant difference in the level of Cho between the CI2H group and the SHAM group.</p><p><strong>Conclusion: </strong>Brain damage in AICAO rats became evident at 2 h after successful modeling. MRS detected brain damage earlier than DWI, with Lac and Lip as the most sensitive markers, preceding changes in NAA, Cho, and ADC values.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-12"},"PeriodicalIF":1.5,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characteristics and Outcomes of Fast Progressors Receiving Endovascular Treatment for Acute Large Vessel Occlusion: A Systematic Review and Meta-Analysis.","authors":"Mingming Zha, Shuaiyu Chen, Jinhua Wang, Yi Xie, Zhihang Huang, Yan E, Ziqi Xu, Benyan Luo, Xiaohao Zhang","doi":"10.1159/000547117","DOIUrl":"10.1159/000547117","url":null,"abstract":"<p><strong>Introduction: </strong>Acute large vessel occlusion patients can be categorized into fast and slow progressors based on infarction growth rate (IGR) before endovascular treatment (EVT). However, the characteristics of fast progressors remain uncertain, and a comprehensive review investigating the adverse effects of fast IGR is needed.</p><p><strong>Methods: </strong>A systematic search of studies published before March 24, 2025, was conducted using PubMed, Web of Science, Embase, and Cochrane Library following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Studies comparing fast and slow progressors before EVT were screened. Baseline characteristics and clinical outcomes were collected. Meta-analysis was performed to pool the results. Weighted odds ratio (OR), mean difference (MD), and confidence intervals (CIs) were calculated. This study was registered on the International Prospective Register of Systematic Reviews platform (CRD420251016945).</p><p><strong>Results: </strong>A total of 8 studies involving 2,718 patients were pooled. Age and gender were similar between fast and slow progressors. Fast progressors had significantly higher baseline National Institute of Health Stroke Scale scores (MD, 2.7; 95% CI, 2.0-3.4; I2 = 0), higher intravenous thrombolysis rates (OR, 1.41; 95% CI, 1.07-1.86; I2 = 62%), larger proportions of internal carotid artery occlusion (OR, 1.74; 95% CI, 1.39-2.19; I2 = 0), and lower percentages of good collateral status (OR, 0.33; 95% CI, 0.22-0.50; I2 = 53%). Cardioembolism etiology was also prevalent in fast progressors (OR, 1.42; 95% CI, 1.10-1.83; I2 = 0). Regarding outcomes, fast IGR was associated with significantly lower rates of successful reperfusion (OR, 0.70; 95% CI, 0.57-0.86; I2 = 0) and a modified Rankin Scale (mRS) score 0-2 at 90-day (OR, 0.34; 95% CI, 0.28-0.42; I2 = 0). Meanwhile, the proportions of symptomatic intracranial hemorrhage (OR, 3.54; 95% CI, 1.78-7.01; I2 = 33%) and 90-day mRS scores (MD, 0.94; 95% CI, 0.61-1.26; I2 = 51%) were higher in fast progressors.</p><p><strong>Conclusion: </strong>Increased stroke severity, proximal vessel occlusion, worse collateral status, and cardioembolism etiology were key features of fast progressors before EVT. Fast progressors exhibit significantly elevated risks of poor outcomes. Taking IGR into consideration during clinical practice and research is essential.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-12"},"PeriodicalIF":1.5,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-Term Outcomes of Endovascular Treatment versus Best Medical Treatment in Patients with Large-Vessel Occlusion Stroke: A Meta-Analysis.","authors":"Can Tang, Chao Liu, Hengzhu Zhang, Wenmiao Luo, Jiaying Li, Mingfei Yang","doi":"10.1159/000546720","DOIUrl":"10.1159/000546720","url":null,"abstract":"<p><strong>Introduction: </strong>For patients with acute ischaemic stroke caused by large vessel occlusion (LVO), there is limited evidence regarding the long-term outcomes of endovascular treatment (EVT) compared with best medical treatment (BMT). The objective of this study was to evaluate the long-term efficacy and safety of EVT in LVO stroke patients.</p><p><strong>Methods: </strong>This study systematically searched electronic databases from January 2015 to August 2024 and included seven eligible trials. These studies reported 1-2 year of follow-up data on functional independence (modified Rankin Scale [mRS] score 0-2), distribution of mRS on shift analysis, quality of life (European Quality of Life 5-Dimensions Questionnaire score), and mortality.</p><p><strong>Results: </strong>A total of 1,236 patients who received EVT and 1,122 who received BMT were included in the analysis. Compared with BMT, EVT was associated with a significantly greater likelihood of functional independence (odds ratio [OR] 2.55, 95% confidence interval [CI], 1.76-3.70), improved distribution of mRS scores on shift analysis (common OR 1.67, 95% CI, 1.37-2.02), and a better quality of life (beta coefficient 0.13, 95% CI, 0.07-0.19) at 1-2 years of follow-up. Compared with BMT, EVT was also associated with lower rates of all-cause mortality (OR 0.67, 95% CI, 0.56-0.81). Compared with 90-day follow-up, long-term follow-up demonstrated an improvement in functional independence among LVO stroke patients (1.7% vs. 0.2%), whereas the increase in mortality was slower (9.3% vs. 11.3%).</p><p><strong>Conclusions: </strong>This meta-analysis indicated that LVO stroke patients can achieve long-term benefits following EVT. The findings provide valuable evidence to inform clinical decision-making.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-10"},"PeriodicalIF":1.5,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and Outcome of Cerebral Microbleeds in Antiphospholipid Syndrome.","authors":"Jonathan Naftali, Rani Barnea, Ruth Eliahou, Sivan Bloch, Tzippy Shochat, Adi Wilf-Yarkoni, Michael Findler, Avi Leader, Walid Saliba, Eitan Auriel","doi":"10.1159/000546784","DOIUrl":"10.1159/000546784","url":null,"abstract":"<p><strong>Introduction: </strong>Antiphospholipid syndrome (APS) is an acquired autoimmune disease characterized by arterial and venous thrombosis. Acute ischemic stroke (AIS) and transient ischemic attack (TIA) are common neurological manifestations in APS patients. Cerebral microbleeds (CMB) are indicators for cerebral small vessel disease and associated with intracerebral hemorrhage (ICH) and AIS. In the present study, we aimed to look at the association and clinical significance of CMB in patients with APS.</p><p><strong>Methods: </strong>This is a retrospective cohort study that utilized data obtained from health service data of more than 5 million patients. We included patients aged 18 and older diagnosed with APS who underwent brain MRI between January 2014 and April 2020 and an age-matched control group with negative APS laboratory results. APS diagnosis was confirmed by positive laboratory findings from two separate tests conducted at least 12 weeks apart. The first available brain MRI was assessed for the presence of CMB. We compared the prevalence of CMB between patients with APS and controls. Among APS patients, we assessed the association between CMB and future AIS/TIA or ICH during 48-month follow-up using Cox proportional hazards models.</p><p><strong>Results: </strong>The study included 276 patients, of which 195 were in the APS group and 81 in the control group. Patients with APS exhibited a higher prevalence of CMB (16% vs. 4%, p < 0.01). Among the APS group, those with CMB had a significantly higher risk of subsequent AIS/TIA (hazard ratio = 8.5, 95% confidence interval [CI]: 3.1-23), cumulative incidence 30% (95% CI: 13%-50%). None of the patients with APS had ICH during follow-up.</p><p><strong>Conclusion: </strong>Patients with APS have a higher prevalence of CMB compared with non-APS individuals, and the presence of CMB in APS patients is associated with an increased risk of AIS/TIA.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-9"},"PeriodicalIF":2.2,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}